Article

Can’t beat a good cup of coffee!

Author(s):

Jon Carter

Check out the latest Optic Relief!

Related Videos
Image credit: Ophthalmology Times; Angiogenesis 2025: Encapsulated cell therapy for MacTel shows long-term efficacy in phase 3 trials
Image credit: Ophthalmology Times; Dean McGee Eye Institute resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO poster
Related Content
FDA approves amended label for Izervay for geographic atrophy
February 13th 2025

FDA approves amended label for Izervay for geographic atrophy

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

OCT biomarkers may predict visual outcomes in nAMD treatment
February 13th 2025

OCT biomarkers may predict visual outcomes in nAMD treatment

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

OKYO Pharma’s lead asset OK-101 receives United States Adopted Name “urcosimod”
February 12th 2025

OKYO Pharma’s lead asset OK-101 receives United States Adopted Name “urcosimod”

Efficacy of teprotumumab in reducing eyelid retraction in TED
February 12th 2025

Efficacy of teprotumumab in reducing eyelid retraction in TED

© 2025 MJH Life Sciences

All rights reserved.